RVNC
BAMCO Inc’s Revance Therapeutics, Inc. RVNC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,023,663
| Closed | -$2.63M | – | 346 |
|
2024
Q2 | $2.63M | Hold |
1,023,663
| – | – | 0.01% | 282 |
|
2024
Q1 | $5.04M | Hold |
1,023,663
| – | – | 0.01% | 268 |
|
2023
Q4 | $9M | Buy |
1,023,663
+3,429
| +0.3% | +$30.1K | 0.02% | 241 |
|
2023
Q3 | $11.7M | Sell |
1,020,234
-102,432
| -9% | -$1.17M | 0.03% | 228 |
|
2023
Q2 | $28.4M | Buy |
1,122,666
+53,183
| +5% | +$1.35M | 0.08% | 173 |
|
2023
Q1 | $34.4M | Sell |
1,069,483
-188,225
| -15% | -$6.06M | 0.1% | 153 |
|
2022
Q4 | $23.2M | Sell |
1,257,708
-462,800
| -27% | -$8.54M | 0.08% | 170 |
|
2022
Q3 | $46.5M | Buy |
1,720,508
+37,500
| +2% | +$1.01M | 0.15% | 118 |
|
2022
Q2 | $23.3M | Buy |
1,683,008
+290,600
| +21% | +$4.02M | 0.07% | 191 |
|
2022
Q1 | $27.2M | Hold |
1,392,408
| – | – | 0.07% | 200 |
|
2021
Q4 | $22.7M | Hold |
1,392,408
| – | – | 0.05% | 250 |
|
2021
Q3 | $38.8M | Buy |
1,392,408
+258,476
| +23% | +$7.2M | 0.09% | 199 |
|
2021
Q2 | $33.6M | Buy |
1,133,932
+42,200
| +4% | +$1.25M | 0.08% | 198 |
|
2021
Q1 | $30.5M | Buy |
1,091,732
+350,000
| +47% | +$9.78M | 0.08% | 187 |
|
2020
Q4 | $21M | Buy |
741,732
+160,000
| +28% | +$4.53M | 0.05% | 212 |
|
2020
Q3 | $14.6M | Hold |
581,732
| – | – | 0.04% | 214 |
|
2020
Q2 | $14.2M | Buy |
581,732
+75,000
| +15% | +$1.83M | 0.05% | 196 |
|
2020
Q1 | $7.5M | Sell |
506,732
-321,000
| -39% | -$4.75M | 0.04% | 210 |
|
2019
Q4 | $13.4M | Hold |
827,732
| – | – | 0.05% | 193 |
|
2019
Q3 | $10.8M | Buy |
827,732
+192,532
| +30% | +$2.5M | 0.04% | 200 |
|
2019
Q2 | $8.24M | Buy |
635,200
+126,000
| +25% | +$1.63M | 0.03% | 233 |
|
2019
Q1 | $8.03M | Buy |
+509,200
| New | +$8.03M | 0.03% | 220 |
|
2015
Q2 | – | Sell |
-30,000
| Closed | -$622K | – | 365 |
|
2015
Q1 | $622K | Sell |
30,000
-13,000
| -30% | -$270K | ﹤0.01% | 344 |
|
2014
Q4 | $728K | Hold |
43,000
| – | – | ﹤0.01% | 334 |
|
2014
Q3 | $831K | Buy |
43,000
+23,000
| +115% | +$444K | ﹤0.01% | 330 |
|
2014
Q2 | $680K | Buy |
20,000
+2,500
| +14% | +$85K | ﹤0.01% | 320 |
|
2014
Q1 | $551K | Buy |
+17,500
| New | +$551K | ﹤0.01% | 328 |
|